Elisa Kortela - Infectious Diseases

Author Information

E. Kortela is a researcher affiliated with the Division of Infectious Diseases at the Inflammation Center of Helsinki University Hospital and the University of Helsinki in Helsinki, Finland. Additionally, E. Kortela is connected with the Department of Clinical Medicine at the University of Turku, situated in Turku, Finland. This dual affiliation with two prominent Finnish universities highlights her active involvement in the infectious diseases field, contributing to both clinical and academic communities.

Research Contributions

E. Kortela has made significant contributions to the field of infectious diseases, particularly focusing on the clinical aspects of SARS-CoV-2 and Lyme borreliosis. Her research includes studies on the prediction of COVID-19 outcomes based on inflammation parameters, the sensitivity of SARS-CoV-2 RT-PCR tests in symptomatic patients, and the healthcare consumption patterns in Lyme borreliosis cases. Notably, her work also covers the evaluation of treatment modalities for Lyme neuroborreliosis and the dynamics of SARS-CoV-2 strains in Finland. These studies provide valuable insights into the management and understanding of infectious diseases.

Aliases

E. Kortela is also known by the aliases "E Kortela" and "Elisa Kortela." These variations of her name appear in different publications and databases.

Publication and Citation Metrics

Total Citation Count	311
h-index	6
Total Paper Count	16

Publications:

Inflammation parameters predict fatal outcome in male COVID-19 patients in a low case-fatality area - a population-based registry study.

DOI: 10.1080/23744235.2022.2055786

Year: 2022

Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

DOI: 10.1371/journal.pone.0251661

Year: 2021

Consumption of healthcare services and antibiotics in patients with presumed disseminated Lyme borreliosis before and after evaluation of an infectious disease specialist.

DOI: 10.1016/j.ttbdis.2021.101854

Year: 2021

Male predominance in disease severity and mortality in a low Covid-19 epidemic and low case-fatality area – a population-based registry study

DOI: 10.1080/23744235.2021.1936157

Year: 2021

The phylodynamics of SARS-CoV-2 during 2020 in Finland — Disappearance and re-emergence of introduced strains.

DOI: 10.21203/rs.3.rs-753457/v1

Year: 2021

Lyme neuroborreliosis-associated cerebrovascular events in the Finnish endemic area

DOI: 10.1016/j.jns.2021.117544

Year: 2021

Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme neuroborreliosis: a multicentre, equivalence, randomized, open-label trial.

DOI: 10.1093/cid/ciaa217

Year: 2020

Real-life clinical sensitivity of SARS-CoV-2 RT-PCR test in symptomatic patients

DOI: 10.1101/2020.11.01.20223107

Year: 2020

Evaluation of commercial and automated SARS-CoV-2 IgG and IgA ELISAs using coronavirus disease (COVID-19) patient samples

DOI: 10.2807/1560-7917.ES.2020.25.18.2000603

Year: 2020

Suspicion of Lyme borreliosis in patients referred to an infectious diseases clinic: what did the patients really have?

DOI: 10.1016/j.cmi.2020.09.022

Year: 2020

How is Herpes Transmitted?

What is the National Institutes of Health (NIH)?

Are There Any Complications?

What are Common Symptoms of Infectious Diseases?

When Should Antipyretics be Used?

How Does Hand Hygiene Prevent Infections?

Are There Any Risks Associated with Symptomatic Relief?

How Do Extreme Weather Events Impact Infectious Disease Spread?

How is the Immune System Studied?

What is the Global Impact of Malaria?

Partnered Content Networks

Relevant Topics